Silence Therapeutics (SLN) Change in Receivables (2024 - 2025)
Silence Therapeutics (SLN) reported Change in Receivables of -$30000.0 for Q4 2025, down 104.91% on a YoY basis from $611000.0 in Q4 2024, and up 51.61% sequentially from -$62000.0 in Q3 2025.
Silence Therapeutics (SLN) Change in Receivables (2024 - 2025) Analysis & Trends
Silence Therapeutics (SLN) has 2 years of Change in Receivables data on file, last reported at -$30000.0 in Q4 2025.
- For the quarter ending Q4 2025, Change in Receivables fell 104.91% year-over-year to -$30000.0; the trailing twelve-month figure through Mar 2026 stood at -$84000.0 (up 99.16% YoY), and the FY2025 full-year result was -$1.0 million, down 213.27% from the prior year.
- Change in Receivables advanced to -$30000.0 in Q4 2025, from -$62000.0 in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $10.0 million in Q1 2024 to a low of -$8.0 million in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 75.30 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2.84 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -39.80 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Silence Therapeutics | 1.62 Bn | 1.49 Bn | 411,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -30,000.00 |
| Dec 31, 2025 | -30,000.00 |
| Sep 30, 2025 | -62,000.00 |
| Sep 30, 2025 | -62,000.00 |
| Jun 30, 2025 | 8,000.00 |
| Jun 30, 2025 | 8,000.00 |
| Mar 31, 2025 | -940,000.00 |
| Mar 31, 2025 | -940,000.00 |
| Dec 31, 2024 | 611,000.00 |
| Dec 31, 2024 | 611,000.00 |
| Sep 30, 2024 | -1.75 Mn |
| Sep 30, 2024 | -1.75 Mn |
| Jun 30, 2024 | -7.97 Mn |
| Jun 30, 2024 | -7.97 Mn |
| Mar 31, 2024 | 10.01 Mn |
| Mar 31, 2024 | 10.01 Mn |